Print Friendly, PDF & Email

NCT/Study#

NCT04551885 /

FT516-102

A Phase I, Open-Label, Multicenter Study Of FT516 In Combination With Monoclonal Antibodies In Subjects With Advanced Solid Tumors

DISEASE GROUP:

Phase 1 Clinical Trials

current phase:

Phase I

STUDY STATUS:

Accepting Patients

Location:

Hackensack, NJ

For More information:

Call 201-518-3587